1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602.
2. De Geest B, Mishra M. Role of oxidative stress in diabetic cardiomyopathy. Antioxidants 2022; 11: 784-803.
3. Goyal BR, Mehta AA. Diabetic cardiomyopathy. Hum Exp Toxicol 2012; 32: 571-590.
4. Gong W, Zhang S, Chen Y, Shen J, Zheng Y, Liu X, et al. Protective role of hydrogen sulfide against diabetic cardiomyopathy via alleviating necroptosis. Free Radic Biol Med 2022; 181: 29-42.
5. Tian H, Xiong Y, Zhang Y, Leng Y, Tao J, Li L, et al. Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Cell Stress Chaperones 2021; 27: 149-164.
6. Wei C, Sun M, Liang X, Che B, Wang N, Shi L, et al. Spermine regulates immune and signal transduction dysfunction in diabetic cardiomyopathy. Front Endocrinol (Lausanne) 2021; 12: 740493-740504.
7. Wang J, Li S, Wang J, Wu F, Chen Y, Zhang H, et al. Spermidine alleviates cardiac aging by improving mitochondrial biogenesis and function. Aging (Albany NY) 2020; 12: 650-671.
8. Zou T, Rao JN, Guo X, Liu L, Zhang HM, Strauch ED, et al. NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am J Physiol Cell Physiol 2004; 286: C1009-1018.
9. Wang Y, Wang Y, Li F, Zhang X, Li H, Yang G, et al. Spermine protects cardiomyocytes from high glucose-induced energy disturbance by targeting the CaSR-gp78-ubiquitin proteasome system. Cardiovasc Drugs Ther 2021; 35: 73-85.
10. Suriano F, Vieira-Silva S, Falony G, Roumain M, Paquot A, Pelicaen R, et al. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: Two sides of the same coin. Microbiome 2021; 9: 1-20.
11. Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L. The db/db mouse, a model for diabetic dyslipidemia: Molecular characterization and effects of Western diet feeding. Metabolism 2000; 49: 22-31.
12. Arrellano-Valdez F, Urrutia-Osorio M, Arroyo C, Soto-Vega E. A comprehensive review of urologic complications in patients with diabetes. Springerplus 2014; 3: 549-557.
13. Lorenzo-Almorós A, Tuñón J, Orejas M, Cortés M, Egido J, Lorenzo Ó. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol 2017; 16: 28-42.
14. Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol 2020; 17: 585-607.
15. Johnson R, Nxele X, Cour M, Sangweni N, Jooste T, Hadebe N, et al. Identification of potential biomarkers for predicting the early onset of diabetic cardiomyopathy in a mouse model. Sci Rep 2020; 10: 12352-12364.
16. Huang L, Li C. Leptin: A multifunctional hormone. Cell Res 2000; 10: 81-92.
17. Xu J, Du WW, Wu N, Li F, Li X, Xie Y, et al. The circular RNA circNlgnmediates doxorubicin-inducedcardiac remodeling and fibrosis. Mol Ther Nucleic Acids 2022; 28: 175-189.
18. Li F, Du WW, Li X, Xu J, Wu N, Awan FM, et al. A novel circular RNA circITGa9 predominantly generated in human heart disease induces cardiac remodeling and fibrosis. Research (Wash D C) 2024; 7: 0303-0320.
19. Al-Habsi M, Chamoto K, Matsumoto K, Nomura N, Zhang B, Sugiura Y, et al. Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice. Science 2022; 378: eabj3510.
20. Hu J, Lu X, Zhang X, Shao X, Wang Y, Chen J, et al. Exogenous spermine attenuates myocardial fibrosis in diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress and the canonical Wnt signaling pathway. Cell Biol Int 2020; 44: 1660-1670.
21. Zhang H, Wang J, Li L, Chai N, Chen Y, Wu F, et al. Spermine and spermidine reversed age-related cardiac deterioration in rats. Oncotarget 2017; 8: 64793-64808.
22. Wang Y, Chen J, Li S, Zhang X, Guo Z, Hu J, et al. Exogenous spermine attenuates rat diabetic cardiomyopathy via suppressing ROS-p53 mediated down-regulation of calcium-sensitive receptor. Redox Biology 2020; 32: 101514-101527.
23. Miyazawa K, Miyazono K. Regulation of TGF-β Family Signaling by Inhibitory Smads. Cold Spring Harb Perspect Biol 2017; 9: a022095-22120.
24. Morikawa M, Derynck R, Miyazono K. TGF-β and the TGF-β family: Context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol 2016; 8: a021873-021887.
25. Rai V, Sharma P, Agrawal S, Agrawal DK. Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research. Mol Cell Biochem 2016; 424: 123-145.
26. Sharma V, Sharma A, Saran V, Bernatchez PN, Allard MF, McNeill JH. β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions. Eur J Pharmacol 2011; 657: 117-125.
27. Avila G, Osornio-Garduño DS, Ríos-Pérez EB, Ramos-Mondragón R. Functional and structural impact of pirfenidone on the alterations of cardiac disease and diabetes mellitus. Cell Calcium 2014; 56: 428-435.
28. Wei H, Li D, Luo Y, Wang Y, Lin E, Wei X. Aluminum exposure induces nephrotoxicity via fibrosis and apoptosis through the TGF-β1/Smads pathway in vivo and in vitro. Ecotoxicol Environ Saf 2023; 249: 114422-114432.
29. Zhang G, Bai R, Huang J, Gao Y, Yun X, Haji AA. Barbaloin attenuates pulmonary fibrosis through TGF-β1/Smads/p38 pathway. J Pharm Pharmacol 2022; 74: 1160-1169.